Literature DB >> 29136511

SnapShot: Chronic Lymphocytic Leukemia.

Elisa Ten Hacken1, Romain Guièze2, Catherine J Wu3.   

Abstract

Despite the recent advances in the therapeutic management of Chronic Lymphocytic Leukemia (CLL) patients, this common B cell malignancy still remains incurable. This SnapShot provides an overview of CLL biology and therapy, with a focus on genetics and microenvironmental interactions, which contribute to disease progression and therapy resistance. To view this SnapShot, open or download the PDF.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2017        PMID： 29136511      PMCID： PMC5858912          DOI： 10.1016/j.ccell.2017.10.015

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  10 in total

1.  Non-coding recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Silvia Beà; Rafael Valdés-Mas; Neus Villamor; Jesús Gutiérrez-Abril; José I Martín-Subero; Marta Munar; Carlota Rubio-Pérez; Pedro Jares; Marta Aymerich; Tycho Baumann; Renée Beekman; Laura Belver; Anna Carrio; Giancarlo Castellano; Guillem Clot; Enrique Colado; Dolors Colomer; Dolors Costa; Julio Delgado; Anna Enjuanes; Xavier Estivill; Adolfo A Ferrando; Josep L Gelpí; Blanca González; Santiago González; Marcos González; Marta Gut; Jesús M Hernández-Rivas; Mónica López-Guerra; David Martín-García; Alba Navarro; Pilar Nicolás; Modesto Orozco; Ángel R Payer; Magda Pinyol; David G Pisano; Diana A Puente; Ana C Queirós; Víctor Quesada; Carlos M Romeo-Casabona; Cristina Royo; Romina Royo; María Rozman; Nuria Russiñol; Itziar Salaverría; Kostas Stamatopoulos; Hendrik G Stunnenberg; David Tamborero; María J Terol; Alfonso Valencia; Nuria López-Bigas; David Torrents; Ivo Gut; Armando López-Guillermo; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2015-07-22       Impact factor: 49.962

2.  DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia.

Authors:  Christopher C Oakes; Marc Seifert; Yassen Assenov; Lei Gu; Martina Przekopowitz; Amy S Ruppert; Qi Wang; Charles D Imbusch; Andrius Serva; Sandra D Koser; David Brocks; Daniel B Lipka; Olga Bogatyrova; Dieter Weichenhan; Benedikt Brors; Laura Rassenti; Thomas J Kipps; Daniel Mertens; Marc Zapatka; Peter Lichter; Hartmut Döhner; Ralf Küppers; Thorsten Zenz; Stephan Stilgenbauer; John C Byrd; Christoph Plass
Journal:  Nat Genet       Date:  2016-01-18       Impact factor: 38.330

Review 3.  Antigen receptor stereotypy in chronic lymphocytic leukemia.

Authors:  K Stamatopoulos; A Agathangelidis; R Rosenquist; P Ghia
Journal:  Leukemia       Date:  2016-11-04       Impact factor: 11.528

Review 4.  Entering the era of targeted therapy for chronic lymphocytic leukemia: impact on the practicing clinician.

Authors:  John C Byrd; Jeffrey J Jones; Jennifer A Woyach; Amy J Johnson; Joseph M Flynn
Journal:  J Clin Oncol       Date:  2014-09-20       Impact factor: 44.544

Review 5.  Chronic lymphocytic leukaemia.

Authors:  Thomas J Kipps; Freda K Stevenson; Catherine J Wu; Carlo M Croce; Graham Packham; William G Wierda; Susan O'Brien; John Gribben; Kanti Rai
Journal:  Nat Rev Dis Primers       Date:  2017-01-19       Impact factor: 52.329

6.  Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.

Authors:  Michael Hallek; Bruce D Cheson; Daniel Catovsky; Federico Caligaris-Cappio; Guillaume Dighiero; Hartmut Döhner; Peter Hillmen; Michael J Keating; Emili Montserrat; Kanti R Rai; Thomas J Kipps
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

Review 7.  Preclinical modeling of novel therapeutics in chronic lymphocytic leukemia: the tools of the trade.

Authors:  Sarah E M Herman; Adrian Wiestner
Journal:  Semin Oncol       Date:  2016-02-08       Impact factor: 4.929

8.  Mutations driving CLL and their evolution in progression and relapse.

Authors:  Dan A Landau; Eugen Tausch; Amaro N Taylor-Weiner; Chip Stewart; Johannes G Reiter; Jasmin Bahlo; Sandra Kluth; Ivana Bozic; Mike Lawrence; Sebastian Böttcher; Scott L Carter; Kristian Cibulskis; Daniel Mertens; Carrie L Sougnez; Mara Rosenberg; Julian M Hess; Jennifer Edelmann; Sabrina Kless; Michael Kneba; Matthias Ritgen; Anna Fink; Kirsten Fischer; Stacey Gabriel; Eric S Lander; Martin A Nowak; Hartmut Döhner; Michael Hallek; Donna Neuberg; Gad Getz; Stephan Stilgenbauer; Catherine J Wu
Journal:  Nature       Date:  2015-10-14       Impact factor: 49.962

9.  Cellular origin and pathophysiology of chronic lymphocytic leukemia.

Authors:  Marc Seifert; Ludger Sellmann; Johannes Bloehdorn; Frederik Wein; Stephan Stilgenbauer; Jan Dürig; Ralf Küppers
Journal:  J Exp Med       Date:  2012-10-22       Impact factor: 14.307

10.  Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition.

Authors:  Jan A Burger; Dan A Landau; Amaro Taylor-Weiner; Ivana Bozic; Huidan Zhang; Kristopher Sarosiek; Lili Wang; Chip Stewart; Jean Fan; Julia Hoellenriegel; Mariela Sivina; Adrian M Dubuc; Cameron Fraser; Yulong Han; Shuqiang Li; Kenneth J Livak; Lihua Zou; Youzhong Wan; Sergej Konoplev; Carrie Sougnez; Jennifer R Brown; Lynne V Abruzzo; Scott L Carter; Michael J Keating; Matthew S Davids; William G Wierda; Kristian Cibulskis; Thorsten Zenz; Lillian Werner; Paola Dal Cin; Peter Kharchencko; Donna Neuberg; Hagop Kantarjian; Eric Lander; Stacey Gabriel; Susan O'Brien; Anthony Letai; David A Weitz; Martin A Nowak; Gad Getz; Catherine J Wu
Journal:  Nat Commun       Date:  2016-05-20       Impact factor: 14.919
  10 in total
  3 in total

1.  Perspective: Biophysical regulation of cancerous and normal blood cell lineages in hematopoietic malignancies.

Authors:  Sing Wan Wong; Stephen Lenzini; Jae-Won Shin
Journal:  APL Bioeng       Date:  2018-05-22

Review 2.  Calcium-dependent signalling in B-cell lymphomas.

Authors:  Fedor Berditchevski; Eanna Fennell; Paul G Murray
Journal:  Oncogene       Date:  2021-10-08       Impact factor: 9.867

3.  Pharmacological modulation of Kv1.3 potassium channel selectively triggers pathological B lymphocyte apoptosis in vivo in a genetic CLL model.

Authors:  Filippo Severin; Andrea Urbani; Tatiana Varanita; Magdalena Bachmann; Michele Azzolini; Veronica Martini; Marco Pizzi; Angelo Paolo Dei Tos; Federica Frezzato; Andrea Mattarei; Paolo Ghia; Maria Teresa Sabrina Bertilaccio; Erich Gulbins; Cristina Paradisi; Mario Zoratti; Gianpietro Carlo Semenzato; Luigi Leanza; Livio Trentin; Ildiko Szabò
Journal:  J Exp Clin Cancer Res       Date:  2022-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.